In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus. - Wikidata - wikimedia - TriplyDB

In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.

In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.

http://www.wikidata.org/entity/Q39793276

about

Hepatitis delta virus: a peculiar virus Interferon alpha for chronic hepatitis D Hepatitis B and Delta Virus: Advances on Studies about Interactions between the Two Viruses and the Infected Hepatocyte Hepatitis delta virus: A fascinating and neglected pathogen Hepatitis delta virus: Making the point from virus isolation up to 2014 Therapeutic Strategies and New Intervention Points in Chronic Hepatitis Delta Virus Infection Armand-Frappier Outstanding Student Award--The emerging role of 25-hydroxycholesterol in innate immunity Direct acting antivirals for the treatment of chronic viral hepatitis Attacking pathogens through their hosts An Interferon Regulated MicroRNA Provides Broad Cell-Intrinsic Antiviral Immunity through Multihit Host-Directed Targeting of the Sterol Pathway Origin of hepatitis delta virus Targeting protein prenylation for cancer therapy A tagging-via-substrate approach to detect the farnesylated proteome using two-dimensional electrophoresis coupled with Western blotting Hepatitis D virus: an update.Hepatitis Delta Virus Detected in Salivary Glands of Sjögren's Syndrome Patients and Recapitulates a Sjögren's Syndrome-Like Phenotype in Vivo.Meta-analysis: antiviral treatment for hepatitis D.Farnesyltransferase--new insights into the zinc-coordination sphere paradigm: evidence for a carboxylate-shift mechanism.The impact of vaccination and antiviral therapy on hepatitis B and hepatitis D epidemiology Interferon-stimulated genes: a complex web of host defenses.Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses.Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon-alpha therapy via mathematical modeling Denying the wolf access to sheep's clothing.Isoprenoids and related pharmacological interventions: potential application in Alzheimer's disease.Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial.The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response.Hepatitis D Virus: A Call to Screening.Roles of carboxyl-terminal and farnesylated residues in the functions of the large hepatitis delta antigen.Natural history and treatment of chronic delta hepatitis.Hepatitis D revival.Is there a role for statins in fungal infections?Animal models of chronic hepatitis delta virus infection host-virus immunologic interactions.Therapy of Delta Hepatitis.Hepatitis D Virus Replication.Treatment of Delta Hepatitis: Today and in the Future - A review.Interferon Control of the Sterol Metabolic Network: Bidirectional Molecular Circuitry-Mediating Host Protection.Exploring the biochemistry of the prenylome and its role in disease through proteomics: progress and potential.Hepatitis Delta Virus: Replication Strategy and Upcoming Therapeutic Options for a Neglected Human Pathogen.Treatment options for hepatitis delta virus infection.Technical Improvement and Application of Hydrodynamic Gene Delivery in Study of Liver Diseases.Investigational drugs in development for Hepatitis D.

P2860

Q21284829-22392EA6-6EC4-4349-9D81-90D1F6048118 Q24234444-29324202-3553-441E-9BA0-8A05AAB233AA Q26775635-3EC8F7D9-7199-477E-B9D1-CEC01145514B Q26777052-D0C3259D-0AB9-444E-B5E3-D2502A262751 Q26783367-379A4FAD-B464-4FA1-A159-7C27679FD68A Q26795919-3386CE03-2922-407D-B4ED-C87FDB5AFEFC Q26800190-C9782B03-7256-4977-B2FA-5458DFB7295E Q27022216-D9AD4571-8717-4437-8FCB-09A4DB7E425F Q27473132-8DDF9D00-1B21-4B6D-B128-DD82722B3DE1 Q28550521-818BBCF4-79CB-44DC-AAA6-B78F15C779F8 Q28752624-3CDB0DAD-1E4D-4FAE-9DB8-9B978D0D5703 Q33679239-09044AF3-E66A-41CC-B743-629CAA27D107 Q33812895-8A49CFE7-EEAA-4117-8F24-86F54F6D6D6D Q34024141-D8D7798C-8F27-4694-A78E-ECE3FE189FA2 Q34047019-E3FF357B-BCBF-4D99-887F-E03EBF71EE35 Q34138307-144C740C-648C-417D-85A9-6C5492642746 Q34188550-86C74BBB-6A92-4DEF-8106-44FB4C7EBB79 Q34338519-D1B6E6C5-630E-47B8-A237-231C9ED78F16 Q34405609-BB7FAF1A-F2A5-4197-AAB7-DB9650CFDA04 Q34457758-245872BE-A39E-4EE5-80E5-0630D7EB55DF Q34577514-6B92D4D6-3AA0-49C9-BE4E-9E9143F87980 Q35169277-32B4F5BB-1CEE-46C9-AF13-53F49BADCDBA Q35634151-E5C953EC-6F49-41CE-853C-9F7108EA1C49 Q36428213-327816CB-0AD5-4961-9ED1-B43E76D91D27 Q36567141-BD911965-9A31-44CD-B1BA-0A3D5CB20A6E Q37182821-A46F7F75-9CDE-49F9-BEBB-DD25A35B1CEE Q37743065-CC5FCF19-ACDB-4CD1-AE14-320A6AF62473 Q37781102-2C4D210E-EBE2-4C0D-A322-AD59F9663125 Q37825968-74F85897-5AC9-4639-AB8F-80481C337BC7 Q38161534-81EA6106-B796-4F0B-9041-2E4DA502630A Q38357110-4E5F65FB-7E90-4A86-96C3-FFFED102239D Q38562544-3AF3F1AA-3C9F-4778-99BD-1D0E8B4A9261 Q38622670-2CAD6F25-01B0-4E05-A4CE-96F43195D67C Q38769975-FD5A0C87-D3D3-4269-8ADA-92C1BA10A9A5 Q39076009-1D060512-5FCB-4510-8E7B-6E9F13B84CBF Q39316007-F1C99B74-D094-4251-9F43-61C419BD6777 Q39414876-60CBBC5B-4FA5-4CC3-B4F4-3AF34FCD5B93 Q39502937-7C759053-C58F-429D-B895-9E574162D08D Q40039939-0721B6A7-DD4E-42DB-BEEF-0D9989BD4585 Q40113645-074D228E-F3C8-4257-BDBE-700A77B8F005

P2860

In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.

http://www.wikidata.org/entity/Q39793276

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.

@en

In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.

@nl

type

label

In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.

@en

In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.

@nl

prefLabel

In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.

@en

In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.

@nl

P1433

Q39793276-0634ED16-6279-4051-9622-74931B8D5C3F

P1476

Q39793276-DD25EDA8-84C1-4010-8922-5894CB7A3A40

P2093

Q39793276-257C93A4-CBB1-4ABB-A789-32EC90A16F0C

Q39793276-264E3E9B-DF03-4FA4-9CCC-0D420F3BBE1C

Q39793276-2A77C121-7D2B-4885-8357-4EDE0957D213

Q39793276-31B39A9F-07D5-47B4-950D-43DE7CD89207

Q39793276-3D9AF61F-0A4E-4A4E-9762-70575D175E2E

Q39793276-8C666AA5-EB6A-419F-B9AF-A8ABD7B3A6AB

Q39793276-D57E069B-C9AE-4951-BD3D-C0C359E449D9

Q39793276-DBB880F2-FB79-45C6-B0C5-2787B2A553D2

Q39793276-E0FC257C-3745-4252-B7FE-A3F12ED9D21D

Q39793276-E4885645-A1F0-4EC1-A3DB-DC2438E06AE8

P2860

Q39793276-03687D70-01ED-4A1A-82DF-C479A8542DFF

Q39793276-0D541E95-C801-45E6-B58D-A78ED6BDC385

Q39793276-103DB7D7-E087-44A1-868A-9FCB0C3EF888

Q39793276-105FEEC1-70A5-474F-9211-6657BFB7CDCE

Q39793276-12FEB8EE-DF41-44F5-B0CC-09334DC53A87

Q39793276-1435D781-A913-4912-A8F2-8EC4058AAA60

Q39793276-16342727-FBCE-4074-B9A3-307944480D19

Q39793276-2BF1EC8B-921C-49FA-89A3-75BB5F3221F8

Q39793276-3A514140-D940-45CF-A325-F88E9DD9012F

Q39793276-4101E0B1-AA57-4DA4-9D87-2D0E69700B26

P304

Q39793276-39E6992D-BB0C-4A7F-9D38-F02F1B4E85B1

P31

Q39793276-FA09B539-AD76-4B9D-9A36-CDA8D1062B2E

P356

Q39793276-644D9C75-A1B7-427F-8F75-541C403E030E

Q39793276-E06810A8-C6E5-45D4-A596-26FE6F816F71

P407

Q39793276-31A023BA-E049-4A4F-B74B-A3A64F7239CE

P433

Q39793276-B4470F03-B6E1-4A39-A90A-A8F7E2E743CE

P478

Q39793276-F29CF79A-3539-4CDD-B683-1ABEBC2FDE40

P50

Q39793276-006C4708-1BF4-4B20-8B25-29414D2ACEB2

Q39793276-EC0CBF14-64A3-4F9E-8A22-F3AF680C4BB0

P577

Q39793276-2FC7F7A8-A06D-4D11-BBF6-7CCB5DFA62DD

P698

Q39793276-E8351E49-EC74-44C2-8AA7-773190EB7BF9

P932

Q39793276-DC6A8483-0A71-4F4D-A2A1-F1F288E3B6A5

P356

P1433

Journal of Clinical Investigation

P1476

In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus

@en

P2093

Andrew D Hamilton

http://www.w3.org/2001/XMLSchema#string

Bruno B Bordier

http://www.w3.org/2001/XMLSchema#string

F H Salazar

http://www.w3.org/2001/XMLSchema#string

Jeffrey S Glenn

http://www.w3.org/2001/XMLSchema#string

Kazuo Ohashi

http://www.w3.org/2001/XMLSchema#string

Leonard Meuse

http://www.w3.org/2001/XMLSchema#string

Mark A Kay

http://www.w3.org/2001/XMLSchema#string

Patricia L Marion

http://www.w3.org/2001/XMLSchema#string

Ping Liu

http://www.w3.org/2001/XMLSchema#string

Said M Sebti

http://www.w3.org/2001/XMLSchema#string

P2860

Posttranslational modification of proteins by isoprenoids in mammalian cells

Protein prenylation: molecular mechanisms and functional consequences

Activation of heterologous gene expression by the large isoform of hepatitis delta antigen.

Small-form hepatitis B surface antigen is sufficient to help in the assembly of hepatitis delta virus-like particles

A phase II trial of farnesyl protein transferase inhibitor SCH 66336, given by twice-daily oral administration, in patients with metastatic colorectal cancer refractory to 5-fluorouracil and irinotecan.

Ras protein farnesyltransferase: A strategic target for anticancer therapeutic development.

Replication of the human hepatitis delta virus genome Is initiated in mouse hepatocytes following intravenous injection of naked DNA or RNA sequences.

Assembly of hepatitis delta virus particles.

Structure, sequence and expression of the hepatitis delta (delta) viral genome.

Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection

P304

407-414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI17704

http://www.w3.org/2001/XMLSchema#string

10.1172/JCI200317704

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12897208

http://www.w3.org/2001/XMLSchema#string

P932

166292

http://www.w3.org/2001/XMLSchema#string